BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31520260)

  • 1. The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas.
    Zhan X; Li L; Wu M; Lang J
    Arch Gynecol Obstet; 2019 Oct; 300(4):1045-1052. PubMed ID: 31520260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer.
    Matsuo K; Machida H; Frimer M; Marcus JZ; Pejovic T; Roman LD; Wright JD
    Gynecol Oncol; 2017 Dec; 147(3):558-564. PubMed ID: 28986093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronous dual primary ovarian and endometrial carcinomas.
    Pearl ML; Johnston CM; Frank TS; Roberts JA
    Int J Gynaecol Obstet; 1993 Dec; 43(3):305-12. PubMed ID: 7907042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does synchronous endometrioid endometrial cancer have any prognostic effect on Stage I endometrioid ovarian cancer?
    Narin MA; Karalok A; Basaran D; Ureyen I; Turkmen O; Turan T; Tulunay G
    Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():113-6. PubMed ID: 27017531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic role of peritoneal cytology in stage IA endometrial endometrioid carcinomas.
    Wang L; Li L; Wu M; Lang J
    Curr Probl Cancer; 2020 Apr; 44(2):100514. PubMed ID: 31753315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers.
    Sozen H; Vatansever D; Iyibozkurt AC; Topuz S; Ozsurmeli M; Salihoglu Y; Guzelbey B; Berkman S
    J Obstet Gynaecol Res; 2015 Nov; 41(11):1813-9. PubMed ID: 26369625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 9. L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma.
    Soovares P; Pasanen A; Bützow R; Lassus H
    Gynecol Oncol; 2017 Sep; 146(3):615-622. PubMed ID: 28625395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
    Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
    Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.
    Cuff J; Longacre TA
    Am J Surg Pathol; 2012 May; 36(5):688-95. PubMed ID: 22498820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronous ovarian and endometrial carcinoma: a strong link to endometriosis?
    Kondi-Pafiti A; Grapsa D; Liapis A; Papadias K; Kairi-Vassilatou E; Hasiakos D
    Eur J Gynaecol Oncol; 2008; 29(3):256-9. PubMed ID: 18592790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognosis of Stage IA Mixed Endometrial Carcinoma.
    Li W; Li L; Wu M; Lang J; Bi Y
    Am J Clin Pathol; 2019 Oct; 152(5):616-624. PubMed ID: 31318970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous endometrial and ovarian carcinomas: predictors of risk and associations with survival and tumor expression profiles.
    Kelemen LE; Rambau PF; Koziak JM; Steed H; Köbel M
    Cancer Causes Control; 2017 May; 28(5):447-457. PubMed ID: 28194593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-based stratification of carcinomas concurrently involving the endometrium and ovary.
    Turashvili G; Gómez-Hidalgo NR; Flynn J; Gonen M; Leitao MM; Soslow RA; Murali R
    Gynecol Oncol; 2019 Jan; 152(1):38-45. PubMed ID: 30413340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of stage I ovarian clear cell and endometrioid carcinomas arising from endometriotic cysts: is it a myth?
    Ayhan A; Akilli H; Haberal N
    Arch Gynecol Obstet; 2019 Jan; 299(1):217-222. PubMed ID: 30315413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma.
    Yoneoka Y; Yoshida H; Ishikawa M; Shimizu H; Uehara T; Murakami T; Kato T
    J Gynecol Oncol; 2019 Jan; 30(1):e7. PubMed ID: 30479091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous endometrioid carcinoma of the uterine corpus and ovary. A case report and review of the literature.
    Grammatoglou X; Skafida E; Glava C; Katsamagkou E; Delliou E; Vasilakaki T
    Eur J Gynaecol Oncol; 2009; 30(4):437-9. PubMed ID: 19761140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous tumours of the female reproductive tract.
    Gilks CB; Kommoss F
    Pathology; 2018 Feb; 50(2):214-221. PubMed ID: 29249564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.